Skip to main content
. 2023 Jul 22;27:73. doi: 10.1186/s40824-023-00405-7

Fig. 2.

Fig. 2

Immuno-antimicrobial regulation of bacterial membrane-coated nanovaccine for the treatment of bacteria. A Illustration diagram of a nanovaccine encapsulated by bacterial outer membrane vesicles (OMVs) for the treatment of Pseudomonas aeruginosa pneumonia. B TEM of LPS@DMON@OMV. C CLSM of inguinal lymph nodes (LNs), which were isolated at 12 h after LPS@DMON@OMV and free OMV-labeled RB injection. D, E Flow cytometry results of surface maturation markers (CD80 and CD86) on CD11c+ DCs. F Immunofluorescence staining of central memory T cells in inguinal LNs and spleen [56]. Copyright©2022 Elsevier B.V